Solventum (SOLV) vs Stryker (SYK)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Solventum (SOLV) has outperformed Stryker (SYK) over the past year, gaining 1.9% versus a loss of 15.8%. Stryker is the larger company by market cap ($118.01 billion vs $14.36 billion), about 8.2 times the size. On valuation, Solventum trades at a lower forward P/E (11.2x vs 19.0x for Stryker).
Stryker pays a dividend yielding 1.14%, while Solventum does not currently pay one. Solventum converts more of its revenue into profit, with a net margin of 18.7% versus 12.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | SOLV | SYK |
|---|---|---|
| Share price | $84.50 | $310.00 |
| Market cap | $14.36B | $118.01B |
| 1-day change | -1.52% | -0.98% |
| YTD return | +6.64% | -11.80% |
| 1-year return | +1.93% | -15.82% |
| 5-year return | — | +27.32% |
| P/E ratio (TTM) | 94.94 | 33.01 |
| Forward P/E | 11.20 | 19.03 |
| EPS (TTM) | $0.89 | $9.39 |
| Dividend yield | 0.00% | 1.14% |
| Annual dividend | $0.00 | $3.52 |
| Revenue (latest FY) | $8.32B | $25.12B |
| Revenue growth (YoY) | +0.86% | +11.16% |
| Net income (latest FY) | $1.56B | $3.25B |
| Gross margin | 53.47% | 63.96% |
| Operating margin | 26.20% | 19.47% |
| Net margin | 18.69% | 12.92% |
| 52-week high | $94.16 | $389.33 |
| 52-week low | $62.38 | $267.00 |
| Distance from 52-week high | -10.26% | -20.38% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +16.43% | +9.47% |
| Average volume | 1.03M | 2.93M |
| Shares outstanding | 169.96M | 380.69M |
| Employees | 20,584 | 56,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Stryker is about 8.2 times larger than Solventum by market value ($118.01B vs $14.36B).
- SOLV has outperformed SYK by 17.8 percentage points over the past year.
- Solventum trades at a higher earnings multiple (94.9x vs 33.0x trailing P/E).
- Stryker offers a meaningfully higher dividend yield (1.14% vs 0.00%).
- Solventum is more profitable, keeping 18.7 cents of every revenue dollar as net income versus 12.9 cents for Stryker.
- Stryker grew revenue faster in its latest fiscal year (+11.16% vs +0.86%).
About Solventum
SOLV stock →Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates through three segments: Medsurg, Dental Solutions, and Health Information Systems.
Health Care · Medical/Dental Instruments · 20,584 employees
About Stryker
SYK stock →Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.
Health Care · Medical/Dental Instruments · 56,000 employees
SOLV vs SYK FAQ
Which is bigger, Solventum or Stryker?
Stryker (SYK) is larger, with a market capitalization of $118.01B compared with $14.36B for Solventum (SOLV).
Which stock has performed better over the past year, SOLV or SYK?
SOLV returned +1.93% over the past 12 months, compared with -15.82% for SYK (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, SOLV or SYK?
SYK has the lower trailing P/E at 33.0, versus 94.9 for SOLV. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Solventum or Stryker?
Stryker pays a dividend yielding 1.14%, while Solventum does not currently pay a regular dividend.
Are Solventum and Stryker in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.